Fact-checked by Grok 2 weeks ago

Pyruvate decarboxylation

Pyruvate decarboxylation refers to the oxidative conversion of pyruvate, the end product of glycolysis, into acetyl-coenzyme A (acetyl-CoA) through the removal of a carboxyl group as carbon dioxide (CO₂), accompanied by the reduction of NAD⁺ to NADH. This irreversible reaction is catalyzed by the pyruvate dehydrogenase complex (PDHc), a large multienzyme assembly located in the mitochondrial matrix of eukaryotic cells and the cytoplasm of prokaryotes. The process serves as a critical link between glycolysis and the tricarboxylic acid (TCA) cycle, enabling the complete oxidation of glucose for ATP production under aerobic conditions. The PDHc consists of three main enzyme components: pyruvate dehydrogenase (E1), dihydrolipoyl transacetylase (E2), and dihydrolipoyl dehydrogenase (E3), along with regulatory kinases and phosphatases. E1 initiates the decarboxylation by facilitating the attachment of pyruvate to thiamine pyrophosphate (TPP), releasing CO₂ and forming hydroxyethyl-TPP, which then transfers the acetyl group to lipoamide on E2, ultimately yielding acetyl-CoA and reduced lipoamide. E3 regenerates oxidized lipoamide using FAD and NAD⁺, producing NADH. Essential cofactors include TPP, lipoic acid, coenzyme A (CoA), FAD, and NAD⁺, with the complex exhibiting a molecular mass of 5–12 MDa and high substrate specificity for pyruvate. In addition to this oxidative pathway, a distinct non-oxidative form of pyruvate decarboxylation occurs in organisms and certain metabolic contexts, such as alcoholic fermentation in , where pyruvate decarboxylase (EC 4.1.1.1) converts pyruvate directly to and CO₂ without NADH production. This enzyme, also TPP- and Mg²⁺-dependent, is homotetrameric and plays a vital role in production by regenerating NAD⁺ for continued . The two pathways highlight pyruvate's metabolic versatility, with the oxidative route dominating in aerobic energy metabolism and the non-oxidative supporting . Regulation of pyruvate decarboxylation is crucial for metabolic flexibility, primarily through of the E1 subunit by pyruvate dehydrogenase kinases (PDKs), which inactivate the complex in response to high energy states (e.g., elevated NADH/NAD⁺ or / ratios), and dephosphorylation by phosphatases under low-energy conditions. Dysregulation of PDHc is implicated in diseases like congenital and certain cancers, underscoring its essential role in maintaining cellular .

Overview

Definition

Pyruvate decarboxylation, also known as pyruvate oxidation or the link reaction, is the oxidative conversion of pyruvate, a three-carbon α-keto acid (CH₃COCOO⁻) and the primary end product of glycolysis, into acetyl-coenzyme A (acetyl-CoA), carbon dioxide (CO₂), and NADH through the action of the pyruvate dehydrogenase complex (PDHc). This irreversible reaction occurs in the mitochondrial matrix of eukaryotic cells and links glycolysis to the tricarboxylic acid (TCA) cycle in aerobic metabolism. The chemical equation is:
Pyruvate + + NAD⁺ → + CO₂ + NADH
The process is classified as an oxidative , involving both and oxidation, in contrast to non-oxidative in pathways. It is catalyzed by the PDHc, a (EC 1.2.4.1 for the overall reaction), which requires cofactors including (TPP), , , , and NAD⁺.

Biological Importance

Pyruvate decarboxylation is essential for aerobic , enabling the complete oxidation of glucose-derived pyruvate for efficient ATP production via the TCA cycle and . By generating , it provides substrates for the TCA cycle, producing additional NADH and FADH₂ for the , yielding up to 30-32 ATP per glucose molecule. This process maintains metabolic by directing pyruvate away from production under aerobic conditions, preventing and supporting energy demands in tissues like and muscle. Dysregulation of PDHc activity is linked to metabolic disorders, including , neurodegenerative diseases, and cancer, where altered flux contributes to disease progression. In addition to its role in eukaryotes, similar oxidative decarboxylation occurs in prokaryotes, underscoring its evolutionary conservation. While a non-oxidative form supports fermentation in and for NAD⁺ regeneration and production, the oxidative pathway dominates in oxygen-rich environments, highlighting pyruvate's central role in metabolic versatility. Industrial applications include biotechnological engineering of PDHc for enhanced biofuel production from renewable feedstocks.

Reaction Details

Chemical Equation

The balanced chemical equation for pyruvate decarboxylation is: \ce{CH3C(O)COO^- + CoA-SH + NAD^+ -> CH3C(O)-S-CoA + CO2 + NADH + H^+} This reaction, also known as the pyruvate dehydrogenase reaction, links to the TCA cycle by producing . The stoichiometry is 1:1:1:1 for pyruvate:CoA:NAD⁺: (or CO₂/NADH), proceeding under physiological (around 7) and aerobic conditions in mitochondria. Thermodynamically, the standard change (ΔG°') is approximately -33.4 kJ/mol at 7 and 25°C, making the reaction highly spontaneous and irreversible due to the favorable and steps. The uncatalyzed reaction has a high , but the PDHc lowers the effective barrier, enabling rapid flux in cellular conditions. The irreversibility is driven by the release of CO₂ and the large negative ΔG°', preventing significant reversal under physiological conditions.

Catalyzing Enzyme

Pyruvate decarboxylation is catalyzed by the (PDHc; EC 1.2.4.1 for the E1 component), a large multienzyme assembly that performs the oxidative decarboxylation of pyruvate to in the of eukaryotic cells and the of prokaryotes. The complex consists of three main enzymes: (E1), dihydrolipoyl transacetylase (E2), and dihydrolipoyl dehydrogenase (E3), with molecular masses ranging from 5–12 MDa depending on the organism. E1 catalyzes the initial decarboxylation using thiamine pyrophosphate (TPP), E2 transfers the acetyl group via lipoic acid to CoA, and E3 regenerates the cofactors using FAD and NAD⁺ to produce NADH. Essential cofactors include TPP, lipoic acid, CoA, FAD, and NAD⁺, ensuring high substrate specificity for pyruvate. The complex exhibits allosteric regulation and phosphorylation-based control by kinases and phosphatases to match metabolic needs.

Mechanism

Structural Basis

The pyruvate dehydrogenase complex (PDHc) is a large, dynamic multienzyme assembly that catalyzes the oxidative decarboxylation of pyruvate to acetyl-CoA in the mitochondrial matrix of eukaryotic cells. It consists of three principal enzymes—E1 (pyruvate dehydrogenase), E2 (dihydrolipoyl transacetylase), and E3 (dihydrolipoyl dehydrogenase)—along with regulatory components, forming a core structure with peripheral attachments and a total molecular mass of approximately 5–12 MDa depending on the organism. In mammals, including humans, the core is built around 48 copies of the E2 core domain arranged in a pentagonal antiprism, with 12 copies of the E3-binding protein (E3BP) facilitating attachment of 12 E3 dimers and up to 46 E1 heterotetramers. This architecture, revealed by recent cryo-electron microscopy (cryo-EM) structures at resolutions of 2.7–3.7 Å, enables substrate channeling via flexible lipoyl domains on E2 that "swing" between active sites. E1 is an α₂β₂ heterotetramer (~400–500 ) that binds (TPP) in its , where the cofactor's thiazolium facilitates . The features two s per tetramer, with conserved residues like Glu-59 (in bacterial E1) coordinating TPP via magnesium and stabilizing intermediates. E2 comprises three domains: the lipoyl domain (with a swinging lipoamide cofactor), the peripheral subunit-binding domain, and the catalytic core domain containing a thiolase-like for acetyl transfer. In human E2, the lipoyl domains are rich in and , allowing dynamic interactions. E3 is a flavin-dependent homodimer (~200–400 ) with bound in a Rossmann fold, linked to NAD⁺ reduction, and its binding to E3BP involves electrostatic interfaces. The overall assembly exhibits icosahedral symmetry in bacterial PDHc but a more asymmetric, open configuration in mammals, with E1 and peripherally associated to the E2/E3BP core. This organization minimizes diffusion of intermediates, enhances efficiency, and allows , as observed in high-resolution structures (e.g., PDB entries 8H5D for core). Essential cofactors include TPP, (on E2), , (on E3), and NAD⁺, with the complex's substrate specificity ensuring selective pyruvate processing.

Catalytic Steps

The catalytic mechanism of PDHc involves coordinated, sequential reactions across its enzymes, linking , acetyl transfer, and reoxidation to produce , CO₂, and NADH from pyruvate, , and NAD⁺. This irreversible process occurs in five main steps, with the lipoyl moiety on E2 serving as a mobile acyl carrier. In the first step, pyruvate binds to the TPP on E1, where the thiazolium C2 nucleophilically attacks the carbonyl carbon, forming the C2α-lactylthiamine () . follows, cleaving the carboxyl group to release CO₂ and generate the hydroxyethylidene-TPP intermediate, stabilized by electrostatic interactions with active-site residues like His-64 and Asp-28 in E1. This is rate-influencing, with kinetic isotope effects indicating a involving C-C bond breakage. Next, the from E1 transfers the to the oxidized lipoamide (-S-S-) on the swinging lipoyl of E2. Nucleophilic attack opens the , yielding acetyl-S-dihydrolipoamide (acetyl-) and a (-SH), while regenerating TPP on E1. The lipoyl then translocates to E2's catalytic core. In the third step, at E2's (a modified fold with His-331 and Asp-421 in human E2), the transfers from the lipoyl to CoA, forming and leaving reduced dihydrolipoamide (two ). This step ensures efficient product formation without free . The lipoyl domain swings to E3, where the fourth step reoxidizes dihydrolipoamide: the vicinal thiols reduce FAD to FADH₂ on E3, reforming the disulfide and releasing the regenerated lipoamide. Finally, E3 transfers electrons from FADH₂ to NAD⁺, producing NADH and regenerating FAD. This redox step, facilitated by E3's dinucleotide-binding domains, completes the cycle and links to the electron transport chain. The overall reaction exhibits pH dependence, with optimal activity around pH 7.0–7.5 in mammalian mitochondria, influenced by TPP ionization (pKa ~6) and protonation states of key residues. Kinetic parameters include a k_cat of ~10–50 s⁻¹ per active site under physiological conditions, underscoring the complex's role in regulated energy metabolism.

Physiological Roles

In Fermentation

In alcoholic fermentation, pyruvate decarboxylation serves as a critical step in the anaerobic conversion of glucose to in . Following , where pyruvate is produced from phosphoenolpyruvate via , pyruvate is decarboxylated by pyruvate decarboxylase (PDC) to form and ; this is then reduced to by (ADH), regenerating NAD⁺ essential for continued . This pathway yields a net of 2 ATP molecules per glucose molecule, as the decarboxylation and subsequent reduction steps do not generate additional ATP beyond glycolysis. In Saccharomyces cerevisiae, the process achieves high efficiency, with over 90% of the theoretical maximum ethanol yield, directing approximately 90% of the carbon from glucose toward ethanol production. Industrial bioethanol production often employs engineered S. cerevisiae strains with PDC overexpression to enhance flux through the fermentation pathway, resulting in elevated ethanol titers, such as up to 20% v/v under optimized conditions. In , PDC plays a key role in sustaining during hypoxic conditions like flooding, where it enables the production of to regenerate NAD⁺ and maintain glycolytic ATP supply for survival. Overexpression of PDC genes, such as PDC1 or PDC2 in , has been shown to improve low-oxygen tolerance by bolstering this pathway.

In Metabolism and Disease

In mammalian metabolism, oxidative pyruvate decarboxylation by the pyruvate dehydrogenase (PDH) complex plays a central physiological role in converting pyruvate to acetyl-CoA, thereby linking glycolysis to the tricarboxylic acid (TCA) cycle and enabling efficient ATP production through aerobic respiration. Non-oxidative pyruvate decarboxylation, catalyzed by pyruvate decarboxylase (PDC), is absent in standard mammalian metabolism. However, PDC-like activity occurs in the human gut microbiota, where certain bacteria and yeasts perform non-oxidative decarboxylation of pyruvate to acetaldehyde during anaerobic fermentation of carbohydrates. This microbial process contributes to endogenous acetaldehyde exposure, with daily levels estimated at approximately 0.1–1 mg/kg body weight, potentially exacerbating local mucosal damage and systemic toxicity, particularly in conditions like bacterial overgrowth. Thiamine deficiency impairs TPP-dependent pyruvate decarboxylation, primarily affecting the PDH complex's E1 subunit in the brain and other tissues, leading to pyruvate accumulation and subsequent lactic acidosis. In beriberi, this manifests as cardiovascular and peripheral symptoms with edema and high lactate levels due to blocked entry into the tricarboxylic acid cycle. Wernicke-Korsakoff syndrome, prevalent in chronic alcoholics, involves neurological damage from similar metabolic disruption, resulting in encephalopathy, ataxia, and memory impairment alongside elevated pyruvate and lactate. Therapeutically, (TPP) supplementation effectively treats these deficiencies by restoring activity; high doses (200–300 mg/day) alleviate symptoms in responsive cases, reducing and improving neurological function. In cancer contexts, PDC has been explored as a targeted therapy to exploit the effect, where nanoparticle-delivered PDC converts excess pyruvate in tumor cells to toxic acetaldehyde, decreasing lactate production by up to 40% and reducing cell viability by ~80% in models. This approach disrupts aerobic without relying on mammalian PDC, offering specificity to high-glycolytic tumors.

Comparisons and Context

With Oxidative Decarboxylation

Pyruvate decarboxylation by pyruvate decarboxylase (PDC) is a non-oxidative process that converts pyruvate to and , without producing NADH, serving as the first step in alcoholic fermentation. In contrast, oxidative decarboxylation by the (PDH) transforms pyruvate into , , and NADH through the net reaction pyruvate + + NAD⁺ → + CO₂ + NADH, linking to the and generating reducing equivalents for . This fundamental difference in products reflects their distinct metabolic roles: PDC enables substrate-level energy recovery under oxygen limitation, while PDH facilitates complete oxidation of pyruvate in energy-demanding aerobic conditions. PDC operates under conditions in the of organisms like , where it supports simple fermentative pathways without requiring complex cellular infrastructure. PDH, however, functions aerobically within the , where its reaction is irreversible due to the strong thermodynamic favorability driven by NADH oxidation in the . These environmental distinctions ensure PDC predominates in low-oxygen niches, such as microorganisms, whereas PDH is essential for in eukaryotic cells. Regulation of PDC involves substrate activation, where pyruvate binds covalently to a regulatory residue (Cys221 in ), inducing an allosteric conformational change that stabilizes active-site loops and enhances catalytic efficiency. PDH regulation is more intricate, featuring covalent modification through of its E1 subunit by pyruvate dehydrogenase kinases (PDKs), which inactivate the complex under high-energy states, and by phosphatases (PDPs) for reactivation; additionally, it undergoes allosteric inhibition by ATP, NADH, and to prevent unnecessary flux when cellular energy is abundant. Both enzymes share (TPP) as a crucial cofactor, with PDC utilizing TPP in a monomeric or homotetrameric structure for , whereas PDH employs TPP specifically in its E1 component as part of a large comprising E1 (), E2 (transacetylase with lipoamide), and E3 ( with and NAD⁺). This structural disparity— a single TPP-dependent for PDC versus a ~2-9 PDH with swinging lipoamide arms for substrate channeling—underlies their differing efficiencies and regulatory complexities .

Evolutionary Aspects

Pyruvate decarboxylation likely originated in ancient prokaryotes as part of early fermentative , predating the around 2.4 billion years ago and aligning with the emergence of primordial pathways in oxygen-poor environments. This process, enabling the non-oxidative conversion of pyruvate to , provided a critical energy-yielding mechanism for early life forms before the of aerobic . In eukaryotes, pyruvate decarboxylase (PDC) activity is inferred to have been present in the last eukaryotic common (LECA) approximately 1.5–2 billion years ago, inherited vertically from the alphaproteobacterial that gave rise to mitochondria and adapted for conditions during the eon. Ancestral sequence reconstruction of bacterial PDC sequences points to a mesophilic bacterial dating back about 1.25 billion years, highlighting its deep prokaryotic roots. The distribution of PDC is widespread but patchy across domains of life, reflecting both conservation and lineage-specific losses. It is ubiquitous in fungi, where it supports fermentative lifestyles, and in , where it facilitates anoxic stress responses such as in flooded roots. In bacteria, PDC occurs sporadically in facultative anaerobes like and Gluconacetobacter diazotrophicus, but is absent in many lineages. Among eukaryotes, it is common in anaerobic protists (e.g., and ) and some vertebrates like and , which use it for production under , but largely missing in most animals that rely on oxidative pathways. This uneven pattern suggests differential retention in anaerobically adapted organisms rather than broad , though some lateral transfers from prokaryotes to early eukaryotes may have occurred. Phylogenetically, PDC evolved from a thiamine pyrophosphate (TPP)-dependent ancestor shared with the E1 subunit of the (PDH) complex, diverging within the broader family of TPP-dependent enzymes after the recruitment of a TH3 in the PDC-like . This split separated non-oxidative decarboxylases like PDC from oxidative ones in the 2-oxoacid (2OXO) group, with PDC forming homotetramers across diverse taxa. appears limited, but vertical inheritance with occasional duplications and losses shaped its spread, as seen in bacterial and eukaryotic lineages. In modern fungi like Saccharomyces cerevisiae, the three PDC genes (PDC1, PDC5, PDC6) arose from gene duplications, with PDC1 encoding the primary isozyme under fermentative conditions, while PDC5 and PDC6 provide redundancy and respond to glucose signaling via repression mechanisms, enhancing metabolic flexibility in high-sugar environments. This diversification allowed subfunctionalization, illustrating how gene copies fine-tuned fermentation efficiency in yeast lineages.

References

  1. [1]
    The Pyruvate Dehydrogenase Complexes: Structure-based Function ...
    The pyruvate dehydrogenase complex (PDC) catalyzes the oxidative decarboxylation of pyruvate with the formation of acetyl-CoA, CO2 and NADH (H+) (1–3). The PDC ...
  2. [2]
    Stoichiometry and architecture of the human pyruvate ... - Science
    Jul 17, 2024 · The pyruvate dehydrogenase complex (PDHc) is a multienzyme assembly that links the two major metabolic pathways of glycolysis and citric acid ...
  3. [3]
    Dynamics of the mammalian pyruvate dehydrogenase complex ...
    Jan 22, 2025 · The multi-enzyme pyruvate dehydrogenase complex (PDHc) links glycolysis to the citric acid cycle and plays vital roles in metabolism, energy production, and ...
  4. [4]
    The pyruvate dehydrogenase complex: Life's essential, vulnerable ...
    Mar 1, 2023 · Found in all organisms, pyruvate dehydrogenase complexes (PDC) are the keystones of prokaryotic and eukaryotic energy metabolism.
  5. [5]
    Pyruvate Dehydrogenase Complex - an overview - ScienceDirect.com
    The pyruvate dehydrogenase complex (PDHc) is the flux-generating step that links carbohydrate substrates from glycolysis to the tricarboxylic acid cycle.
  6. [6]
    Pyruvate Dehydrogenase Complex and TCA Cycle
    The PDH activity (E1) is a heterotetrameric complex composed of two α (alpha) and two β (beta) subunits. The α subunits are primarily encoded by the PDHA1 gene.
  7. [7]
    Structural diversity of pyruvate dehydrogenase complexes - Bothe
    Aug 13, 2025 · The pyruvate dehydrogenase complex (PDHc) is a large 5–12 MDa metabolic enzyme complex. It converts pyruvate to acetyl-CoA, a substrate for ...Abstract · Abbreviations · Different PDHc core... · Peripheral subunits and their...
  8. [8]
    Pyruvate Decarboxylase - an overview | ScienceDirect Topics
    Pyruvate decarboxylase (PDC) is an enzyme that catalyzes the irreversible, non-oxidative decarboxylation of pyruvate to acetaldehyde, releasing carbon dioxide.
  9. [9]
    Decarboxylation of Pyruvate to Acetaldehyde for Ethanol Production ...
    Pyruvate decarboxylase (PDC encoded by pdc) is a thiamine pyrophosphate (TPP)-containing enzyme responsible for the conversion of pyruvate to acetaldehyde ...
  10. [10]
    Role of the Pyruvate Dehydrogenase Complex in Metabolic ...
    Aug 21, 2018 · The multifunctional PDC regulates metabolic reprogramming involved in pyruvate metabolism to maintain homeostasis and survival. Additionally, ...
  11. [11]
    Mitochondrial pyruvate transport: a historical perspective and future ...
    Pyruvate is the end-product of glycolysis, a major substrate for oxidative metabolism, and a branching point for glucose, lactate, fatty acid and amino acid ...
  12. [12]
    End Products Of Glycolysis and Fate of Pyruvate - Microbe Notes
    Apr 6, 2022 · Two molecules of pyruvate are produced from a single glucose molecule during glycolysis. It is a three-carbon molecule with a carboxylic group ...
  13. [13]
    Pyruvate Decarboxylase - an overview | ScienceDirect Topics
    Pyruvate decarboxylase (PDC; EC 4.1.1.1) is another interesting enzyme. It catalyzes non-oxidative decarboxylation of pyruvate into acetaldehyde. This ...
  14. [14]
    Looking Back: A Short History of the Discovery of Enzymes and How ...
    Finally, in 1897, Eduard Büchner showed that a dead yeast extract could carry out the same fermentation reaction as living yeast, thus dealing the final ...
  15. [15]
    Metabolism without Oxygen – Biology - UH Pressbooks
    Anaerobic cellular respiration converts energy without oxygen, using organic molecules (fermentation) or inorganic molecules as electron acceptors.  ...
  16. [16]
  17. [17]
    Thermostable and O2-Insensitive Pyruvate Decarboxylases from ...
    Aug 22, 2022 · Pyruvate decarboxylase (PDC) is a key enzyme involved in ethanol fermentation, and it catalyzes the decarboxylation of pyruvate to acetaldehyde ...
  18. [18]
    Biochemistry and Evolution of Anaerobic Energy Metabolism in ...
    Here we review the available biochemical data on the enzymes and pathways that eukaryotes use in anaerobic energy metabolism and summarize the metabolic end ...
  19. [19]
  20. [20]
    Structure and functional characterization of pyruvate decarboxylase ...
    Nov 5, 2014 · The activation energy of GdPDC on pyruvate was determined in the linear range from 25°C to 45°C to be 46 kJ/mol, which is in agreement with ...
  21. [21]
    1PVD: CRYSTAL STRUCTURE OF THE THIAMIN ... - RCSB PDB
    Pyruvate decarboxylase is a homotetrameric enzyme which crystallizes with two subunits in an asymmetric unit. The structure has been refined by a combination of ...
  22. [22]
    PDC6 | SGD - Saccharomyces Genome Database
    Jun 1, 2007 · PDC6 encode three different isozymes of pyruvate decarboxylase (2, 10, 1), an enzyme which catalyzes the degradation of pyruvate into acetaldehyde and carbon ...
  23. [23]
    Crystal structure of the thiamin diphosphate-dependent enzyme ...
    Mar 1, 1996 · Pyruvate decarboxylase is a homotetrameric enzyme which crystallizes with two subunits in an asymmetric unit. The structure has been refined by ...Missing: properties | Show results with:properties
  24. [24]
    Structure and properties of pyruvate decarboxylase and site-directed ...
    Jun 16, 1998 · Pyruvate decarboxylase (EC 4.1.1.1) is a thiamin diphosphate-dependent enzyme that catalyzes the penultimate step in alcohol fermentation.
  25. [25]
    Covalently Bound Substrate at the Regulatory Site of Yeast Pyruvate ...
    The mechanism by which the enzyme pyruvate decarboxylase from two yeast species is activated allosterically has been elucidated.Missing: ATP | Show results with:ATP
  26. [26]
    Independent, Glucose-Tolerant, and Pyruvate-Hyperproducing Yeast
    S. cerevisiae contains three structural genes (PDC1, PDC5, and PDC6) that encode active pyruvate decarboxylase isoenzymes (18). Pyruvate decarboxylase was long ...
  27. [27]
    Autoregulation of yeast pyruvate decarboxylase gene expression ...
    Deletion of the more strongly expressed PDC1 gene stimulates the promoter activity of both PDC1 and PDC5, a phenomenon called Pdc autoregulation.Missing: ATP | Show results with:ATP
  28. [28]
    Genomic Expression Programs in the Response of Yeast Cells to ...
    Oct 13, 2017 · We explored genomic expression patterns in the yeastSaccharomyces cerevisiae responding to diverse environmental transitions.
  29. [29]
  30. [30]
  31. [31]
    Reaction mechanisms of thiamin diphosphate enzymes
    Reaction mechanisms of thiamin diphosphate enzymes: defining states of ionization and tautomerization of the cofactor at individual steps - PMC.
  32. [32]
    Double Duty for a Conserved Glutamate in Pyruvate Decarboxylase
    Pyruvate decarboxylase (PDC) catalyzes the nonoxidative decarboxylation of pyruvate into acetaldehyde and carbon dioxide and requires thiamin diphosphate ...
  33. [33]
    7.8: Fate of Pyruvate - Chemistry LibreTexts
    May 12, 2024 · Alcoholic fermentation consists of pyruvate being first converted into acetaldehyde by the enzyme pyruvate decarboxylase and releasing CO2. In ...Missing: free energy
  34. [34]
    Energy coupling in Saccharomyces cerevisiae: selected ...
    In S. cerevisiae, alcoholic fermentation via the Embden–Meyerhof–Parnas (EMP) pathway yields two ATP per glucose, whereas the Entner–Doudoroff (ED) pathway ...<|control11|><|separator|>
  35. [35]
    From Saccharomyces cerevisiae to Ethanol: Unlocking the Power of ...
    During industrial-scale ethanol production, S. cerevisiae has a yield higher than 90% of the theoretical maximum which is approximately 0.51 g ethanol per g of ...
  36. [36]
    Optimizing Ethanol Production in Saccharomyces cerevisiae at ...
    Sep 8, 2023 · Glucose consumption is directly related to growth and ethanol production because the amount of glucose used indicates how well the yeast grows ...
  37. [37]
    Saccharomyces cerevisiae strains used industrially for bioethanol ...
    Strain selected for use in high-gravity fermentations at elevated temperatures (up to 38°C), and high sugar and alcohol concentrations (over 20% volume).
  38. [38]
    Enhanced Low Oxygen Survival in Arabidopsis through Increased ...
    We show that overexpression of either PDC1 or PDC2 improved plant survival under low oxygen conditions. This confirms that PDC is the metabolic control point in ...Results · Manipulation Of Pdc Levels · Pdc Overexpression Enhances...
  39. [39]
    Tolerance of anaerobic conditions caused by flooding during ...
    The first reaction in the alcoholic fermentation pathway is the conversion of pyruvate generated during glycolysis to acetaldehyde by the enzyme pyruvate ...
  40. [40]
    Absence of pyruvate decarboxylase activity in man - PubMed
    A complete deficiency in the pyruvate dehydrogenase system activity contributed to the death of a 6-month-old infant with congenital lactic acidosis.
  41. [41]
  42. [42]
    Acetaldehyde as a Food Flavoring Substance: Aspects of Risk ...
    Oct 15, 2023 · Acetaldehyde is formed endogenously in mammalian intermediary metabolism, e.g., during oxidative decarboxylation of pyruvate or in the course of ...Missing: gut microbiota
  43. [43]
    The importance of thiamine (vitamin B1) in humans - Portland Press
    Clinically, deficiency result in various pathologies, most notably, beriberi, a cardiomyopathy with edema and lactic acidosis, and Wernicke–Korsakoff syndrome ...
  44. [44]
    Thiamin | Linus Pauling Institute | Oregon State University
    Thiamin deficiency affecting the central nervous system is referred to as Wernicke's disease when the amnesic state is not present and Wernicke-Korsakoff ...
  45. [45]
    A pyruvate decarboxylase-mediated therapeutic strategy for ... - NIH
    Pyruvate is the substrate for both the citric acid cycle (aerobic metabolism) and lactic acid fermentation (anaerobic metabolism).
  46. [46]
    Regulation of pyruvate metabolism and human disease - PMC
    Aberrant pyruvate metabolism plays an especially prominent role in cancer, heart failure, and neurodegeneration.
  47. [47]
  48. [48]
  49. [49]
    Pyruvate decarboxylase - Wikipedia
    Pyruvate decarboxylase is an enzyme (EC 4.1.1.1) that catalyses the decarboxylation of pyruvic acid to acetaldehyde. It is also called 2-oxo-acid ...
  50. [50]
    Cloning of PDC5, a Gene Homologous to PDC1 - PubMed
    Two DNA fragments with sequences homologous to that of the PDC1 gene were cloned from the yeast genome. ... Deletion of PDC1 led to increased expression of ...Missing: duplication | Show results with:duplication